HALO
NASDAQ · Biotechnology
Halozyme Therapeutics Inc
$103.63
-19.33 (-15.72%)
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Q4 FY2026 | $2.40 | — | — | — | — |
| Aug 6, 2026 | Q3 FY2026 | $1.85 | — | — | — | — |
| May 12, 2026 | Q2 FY2026 | $1.56 | — | — | — | — |
| Feb 24, 2026 | Q1 FY2026 | $2.24 | — | — | — | — |